Pipeline

Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases

BioSpace

George Church's Rejuvenate Bio is turning to social networks to help fund its work on one-time gene therapies targeting chronic diseases and root causes of aging.

Gene Therapy Platform

Read full story

pharminent April 27, 2026 (Last updated: April 27, 2026)

BioSpace

George Church’s Rejuvenate Bio is turning to social networks to help fund its work on one-time gene therapies targeting chronic diseases and root causes of aging.

Gene Therapy Platform

Read full story

Related Stories

Pfizer culls early PD-L1 asset after series of clinical wins, deals in cancer

BBOT shakes up leadership as RAS competitors get more visibility

Roche insists amylin obesity drug still valuable for patients who ‘don’t want side effects’

You May Have Missed

GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio

Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases

J&J puts blockbuster blood thinner Xarelto on TrumpRx

Eli Lilly acquires Ajax Therapeutics for first-in-class JAK2 inhibitor in myelofibrosis